Solaris Pharma Corporation was founded in 2014 with the vision of improving the patients’ quality of life through development of niche pharmaceutical products. Located in Bridgewater, New Jersey, Solaris Pharma Corporation has a fully equipped Research & Development facility with expertise in the development of generic and specialty products. Solaris Pharma Corporation is uniquely poised to develop specialty dermatology products that have a relatively high barrier to entry due to manufacturing complexities and high-end clinical patient study demands.

With a thorough knowledge of the development life cycle and well-trained, committed scientific personnel, Solaris Pharma Corporation has streamlined processes that are efficient in reducing development costs and shortening timelines, without compromise in quality.

Solaris Pharma Corporation is currently engaged in the development of several generic dermatology products and is committed to establish itself as a pacesetter in dermatology pharmaceuticals.

Solaris Pharma Corporation

Solaris Pharma's 2023 Annual Holiday Celebration!

Solaris Pharma would like to wish everyone and their families a Blessed, Safe and Happy Thanksgiving! 

Solaris is currently in the development of several generic dermatology products & is committed to establish itself as a pacesetter in dermatology pharmaceuticals. We are looking for a F/T R&D Scientist with Tech Transfer experience. If you're interested or know someone, contact me at 908-800-0323 or rmarrero@solaris-pharma.com

How are you today? Tell us what you want to hear from us.

If you want to stay up-to-date with us, follow our Page.

CrUX Dataset

CrUX Top 50m

Lakshmi Raghavan

Founder & President

Satish Pejaver

Northeastern US Companies With Less Than $10M in Revenue (Top 10K)

New Jersey Companies With Fewer Than 100 Employees (Top 10K)

East Coast Companies (Top 10K)

Pharmaceutical Companies With More Than 10 Employees (Top 10K)

Solaris Pharma is a fully equipped Research & Development facility with expertise in the development of generic and specialty products. They have the vision of improving the patients’ quality of life through the development of niche pharmaceutical products. 

Solaris Pharma Corporation has a fully equipped Research & Development facility with expertise in the development of generic and specialty products. Solaris Pharma Corporation is uniquely poised to develop specialty dermatology products that have a relatively high barrier to entry due to manufacturing complexities and high-end clinical patient study demands.

Solaris Pharma Corporation was founded in 2014 and is located in Bridgewater, New Jersey.

Venture Round - Solaris Pharma

Bridgewater

New Jersey

United States

North America

Solaris Pharma

Solaris Pharma Receives FDA Approval for Generic Metrogel-Vaginal®

Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%)

Thailand

Asia

Pakistan

Bangladesh

HTML5

GoDaddy Premium DNS

Google Analytics

Google Compute Engine

Office 365

Google Tag Manager

Microsoft Outlook

Google Maps API

Google Fonts

GreenSock Animation Platform

Atlas Pharmaceuticals is a competitor of Solaris Pharma Corporation. They are involved in the development and marketing of specialty pharmaceutical products.

Atlas Pharmaceuticals

Castun Research LLC is a competitor of Solaris Pharma Corporation. They are engaged in the identification, development, and marketing of complex high-quality pharmaceutical products.

Castun Research LLC

Vertice Pharma LLC is a competitor of Solaris Pharma Corporation. They are committed to developing and marketing specialty pharmaceutical products.

Vertice Pharma LLC

Profounda Inc is a competitor of Solaris Pharma Corporation. They are dedicated to identifying, developing, and marketing high-quality specialty pharmaceutical products.

Profounda Inc

Revance Therapeutics is a competitor of Solaris Pharma Corporation. They are involved in the development and marketing of specialty pharmaceutical products.

Revance Therapeutics

Castle Creek Pharma is a competitor of Solaris Pharma Corporation. They are engaged in the identification, development, and marketing of complex high-quality pharmaceutical products.

Castle Creek Pharma

Laboratory Research and Innovation Group - LRIG is a competitor of Solaris Pharma Corporation. They are dedicated to developing and marketing specialty pharmaceutical products.

Laboratory Research and Innovation Group - LRIG

Somerset Therapeutics is a competitor of Solaris Pharma Corporation. They are committed to identifying, developing, and marketing high-quality specialty pharmaceutical products.

Somerset Therapeutics

Catalent is a competitor of Solaris Pharma Corporation. They are involved in the development and marketing of specialty pharmaceutical products.

Catalent

Renacon Pharma is a competitor of Solaris Pharma Corporation. They are dedicated to developing and marketing specialty pharmaceutical products.

Renacon Pharma

Pharco Impex '93 is a competitor of Solaris Pharma Corporation. They are committed to identifying, developing, and marketing high-quality specialty pharmaceutical products.

Pharco Impex '93

Laphal is a competitor of Solaris Pharma Corporation. They are involved in the development and marketing of specialty pharmaceutical products.

Laphal

Basic Pharma is a competitor of Solaris Pharma Corporation. They are dedicated to developing and marketing specialty pharmaceutical products.

Basic Pharma

Solaris Pharma Corporation is a leading specialty pharmaceutical company committed to identifying, developing, and marketing complex high-quality, generic, and specialty pharmaceutical products.

news impact assignment basic	general	May 2, 2024 4:16 PM	4709f2d2
public peers	general	May 2, 2024 4:16 PM	25dc090f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 2, 2024 4:16 PM	63122996
company summary	general
signals	general
crunchbase trigger	general	Oct 29, 2024 5:10 PM	93cadefe
crunchbase profile	general	Oct 30, 2024 6:45 AM	fc2ae124
li profile	general	May 2, 2024 4:16 PM	b75174da
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	044054ee
peers	general
news basic	general	May 2, 2024 4:16 PM	22c3fefd
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:SOLARIS-PHARMA

Solaris Pharma Corporation